Guardion Health Science (GHSI) - Cash Funds Calculated per Share

Symbol and logo of brand Guardion Health (GHSI)

The implementation of AI manipulators in capsule production could boost capitalization, as evidenced by the cash per share trend, where the value is fixed at 11.55. Guardion Health Science (GHSI) revenues are based on the sale of Lumega-Z nutraceuticals designed to combat retinal degeneration. Physician confidence is driven by scientifically proven formulas that slow vision loss, creating a sustainable market advantage.

GHSI Guardion Health: Cash Funds per Share in the range 07/04/2022 - 10/19/2024

Comprehensive metric breakdowns and analytics for Guardion Health Sciences (GHSI)

- cash and cash flow data:
Summary company analysis:GHSI (Guardion Health Sciences Inc.)
Flagship merchandise of guardionhealth.com

This metric is calculated by dividing the total cash balance by the number of shares outstanding. This figure compares current capital with historical context to assess financial stability or stagnation. For Guardion Health Science (GHSI), the value 11.55 reflects the liquidity required to automate production lines for ophthalmological nutraceuticals. Investments in AI manipulators directly impact the dynamics of this reserve. By analyzing the current cash per share, an investor determines the company's ability to fund technological expansion.